Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Cassava Sciences Inc (FLNA) vs Howmet Aerospace Inc (HWM) Price & Performance

Cassava Sciences IncTrade
Howmet Aerospace IncTrade

Price performance (Past 24H)

Key statistics

Cassava Sciences Inc vs Howmet Aerospace Inc — how do they compare? Cassava Sciences Inc trades at $1.06 (market cap $53.14M), while Howmet Aerospace Inc trades at $270.1 (market cap $111.73B). The key difference: Howmet Aerospace Inc is far larger — about 2102.6× Cassava Sciences Inc's market cap, and Howmet Aerospace Inc pays a 0.17% dividend while Cassava Sciences Inc pays none. Which is the better fit depends on your goals.

FLNAHWM
Market Cap
$53.14M$111.73B
Sector
HealthIndustrials
52-Week High
$4.64$283.23
52-Week Low
$1.09$171.00
Enterprise Value
-$33.43M$113.98B
Dividend Yield
0.17%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Cassava Sciences Inc

FLNA trades at $1.06, down 2.75% today, with a bearish technical signal from moving averages but neutral oscillators. The stock shows a low P/B of 0.78, yet profitability metrics are negative, including a -79.59% ROE and -$90.97M net income for 2025. Recent Q1 2026 earnings beat expectations, and analyst consensus is 66.7% buy. News highlights Q1 financial results and a scientific presentation on TSC-related epilepsy therapies.

Outlook remains speculative due to persistent losses and negative cash flows, offset by strong analyst support and recent earnings beats. Key risks include funding needs for drug development and competitive pressures, while potential upside hinges on clinical progress in TSC-related epilepsy treatments.

Howmet Aerospace Inc

Howmet Aerospace (HWM) trades at $268.89, down 2.85% on the day but maintains strong bullish technical momentum with consistent earnings beats. The company reported robust Q1 2026 EPS of $1.22, exceeding expectations, driven by commercial aerospace demand. Valuation ratios remain elevated with a P/E of 64.79, reflecting growth premiums. Analyst consensus is overwhelmingly positive with 84% buy ratings and a $317.63 price target, indicating 18% upside potential from current levels.

Outlook remains favorable with aerospace cycle strength and defense contracts supporting revenue growth, though high valuation multiples pose sensitivity risks. Key risks include execution challenges in meeting production targets and macroeconomic pressures on travel demand. The stock's trajectory hinges on Q2 2026 results due August 6, 2026, where another beat could validate premium pricing.

Returns comparison

Trailing returns across standard periods

About Cassava Sciences Inc

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease

Read more on FLNA

About Howmet Aerospace Inc

Howmet Aerospace provides advanced engineered solutions for the aerospace and transportation industries. It specializes in jet engine components, aerospace fastening systems, and forged aluminum wheels.

Read more on HWM